scispace - formally typeset
Search or ask a question
Institution

University of Jena

EducationJena, Thüringen, Germany
About: University of Jena is a education organization based out in Jena, Thüringen, Germany. It is known for research contribution in the topics: Laser & Population. The organization has 22198 authors who have published 45159 publications receiving 1401514 citations. The organization is also known as: Friedrich-Schiller-Universität Jena & Friedrich Schiller University Jena.


Papers
More filters
Book ChapterDOI
Holger Gies1
TL;DR: In this paper, the authors present a lecture course intended to fill the gap between graduate courses on quantum field theory and specialized reviews or forefront-research articles on functional renormalization group approaches to quantum fields and gauge theories.
Abstract: This lecture course is intended to fill the gap between graduate courses on quantum field theory and specialized reviews or forefront-research articles on functional renormalization group approaches to quantum field theory and gauge theories.

450 citations

Journal ArticleDOI
TL;DR: This project will aid the identification and quantification of properties and mutual effects of antioxidants, bring a more rational basis to the classification of antioxidant assays with their constraints and challenges, and make the results more comparable and understandable.
Abstract: The chemical diversity of natural antioxidants (AOXs) makes it difficult to sepa- rate, detect, and quantify individual antioxidants from a complex food/biological matrix. Moreover, the total antioxidant power is often more meaningful to evaluate health beneficial effects because of the cooperative action of individual antioxidant species. Currently, there is no single antioxidant assay for food labeling because of the lack of standard quantification methods. Antioxidant assays may be broadly classified as the electron transfer (ET)- and hydrogen atom transfer (HAT)-based assays. The results obtained are hardly comparable because of the different mechanisms, redox potentials, pH and solvent dependencies, etc. of various assays. This project will aid the identification and quantification of properties and mutual effects of antioxidants, bring a more rational basis to the classification of antioxidant assays with their constraints and challenges, and make the results more comparable and understandable. In this regard, the task group members convey their own experiences in var- ious methods of antioxidants measurement.

450 citations

Journal ArticleDOI
TL;DR: Results confirm that prejudice changes systematically with age during childhood but that no developmental trend is found in adolescence, indicating the stronger influence of the social context on prejudice with increasing age.
Abstract: This meta-analysis summarizes 113 research reports worldwide (121 cross-sectional and 7 longitudinal studies) on age differences in ethnic, racial, or national prejudice among children and adolescents. Overall, results indicated a peak in prejudice in middle childhood (5-7 years) followed by a slight decrease until late childhood (8-10 years). In addition to differences for the various operationalizations of prejudice, detailed findings revealed different age-related changes in prejudice toward higher versus lower status out-groups and positive effects of contact opportunities with the out-group on prejudice development. Results confirm that prejudice changes systematically with age during childhood but that no developmental trend is found in adolescence, indicating the stronger influence of the social context on prejudice with increasing age.

450 citations

Journal ArticleDOI
TL;DR: It is shown that galectin-1 (Gal-1), an immunoregulatory glycan-binding protein, has a pivotal role in conferring fetomaternal tolerance and is a pivotal regulator of fetom maternal tolerance that has potential therapeutic implications in threatened pregnancies.
Abstract: A successful pregnancy requires synchronized adaptation of maternal immune-endocrine mechanisms to the fetus. Here we show that galectin-1 (Gal-1), an immunoregulatory glycan-binding protein, has a pivotal role in conferring fetomaternal tolerance. Consistently with a marked decrease in Gal-1 expression during failing pregnancies, Gal-1–deficient (Lgals1−/−) mice showed higher rates of fetal loss compared to wild-type mice in allogeneic matings, whereas fetal survival was unaffected in syngeneic matings. Treatment with recombinant Gal-1 prevented fetal loss and restored tolerance through multiple mechanisms, including the induction of tolerogenic dendritic cells, which in turn promoted the expansion of interleukin-10 (IL-10)–secreting regulatory T cells in vivo. Accordingly, Gal-1's protective effects were abrogated in mice depleted of regulatory T cells or deficient in IL-10. In addition, we provide evidence for synergy between Gal-1 and progesterone in the maintenance of pregnancy. Thus, Gal-1 is a pivotal regulator of fetomaternal tolerance that has potential therapeutic implications in threatened pregnancies.

449 citations

Journal ArticleDOI
Danila Seidel1, Thomas Zander1, Lukas C. Heukamp2, Martin Peifer1, Marc Bos2, Lynnette Fernandez-Cuesta2, Frauke Leenders2, Xin Lu2, Sascha Ansén2, Masyar Gardizi2, Chau Nguyen3, Chau Nguyen2, Johannes Berg2, Prudence A. Russell, Zoe Wainer4, Hans-Ulrich Schildhaus5, Hans-Ulrich Schildhaus2, Toni-Maree Rogers, Benjamin Solomon, William Pao6, Scott L. Carter7, Gad Getz7, D. Neil Hayes8, Matthew D. Wilkerson8, Erik Thunnissen9, William D. Travis10, Sven Perner11, Gavin M. Wright4, Elisabeth Brambilla, Reinhard Buettner2, Juergen Wolf2, Roman K. Thomas1, Franziska Gabler1, Ines Wilkening1, Christian Mueller2, Ilona Dahmen2, Roopika Menon11, Katharina Koenig2, Kerstin Albus2, Sabine Merkelbach-Bruse2, Jana Fassunke2, Katja Schmitz2, Helen Kuenstlinger2, Michaela Angelika Kleine2, Elke Binot2, Silvia Querings1, Janine Altmueller2, Ingelore Boessmann2, Peter Nuemberg2, Peter M. Schneider2, Magdalena Bogus2, Alex Soltermann12, Holger Moch12, Odd Terje Brustugun13, Steinar Solberg13, Marius Lund-Iversen13, Åslaug Helland13, Thomas Muley14, Hans Hoffmann14, Philipp A. Schnabel14, Yuan Chen15, Harry J.M. Groen16, Wim Timens, Hannie Sietsma, Joachim H. Clement15, Walter Weder12, Joerg Saenger, Erich Stoelben, Corinna Ludwig, Walburga Engel-Riedel, Egbert F. Smit, Danille A. M. Heideman9, Peter J.F. Snijders9, Lucia Nogova2, Martin L. Sos1, Christian Mattonet2, Karin Toepelt2, Matthias Scheffler2, Eray Goekkurt17, Eray Goekkurt2, Rainer Kappes2, Stefan Krueger2, Kato Kambartel2, Dirk Behringer2, Wolfgang Schulte2, Wolfgang Galetke2, Winfried Randerath2, Matthias Heldwein2, Andreas Schlesinger2, Monika Serke2, Khosro Hekmat2, Konrad Frank2, Roland Schnell2, Marcel Reiser2, Ali-Nuri Huenerlituerkoglu2, Stephan Schmitz2, Lisa Meffert2, Yon-Dschun Ko2, Markus Litt-Lampe2, Ulrich Gerigk2, Rainer Fricke, Benjamin Besse, Christian Brambilla18, Sylvie Lantuejoul18, Philippe Lorimier, Denis Moro-Sibilot18, Federico Cappuzzo, C. Ligorio19, Stefania Damiani19, John K. Field20, Russell Hyde20, Pierre Validire, Philippe Girard, Lucia Anna Muscarella, Vito Michele Fazio, Michael Hallek2, Jean-Charles Soria21, Viktor Achter2, Ulrich Lang2 
TL;DR: Support is provided for broad implementation of genome-based diagnosis of lung cancer by demonstrating the correlation between lung tumor subtype and its predominant mutations, and the benefit of genetic testing and targeted therapy in these patients.
Abstract: We characterized genome alterations in 1255 clinically annotated lung tumors of all histological subgroups to identify genetically defined and clinically relevant subtypes. More than 55% of all cases had at least one oncogenic genome alteration potentially amenable to specific therapeutic intervention, including several personalized treatment approaches that are already in clinical evaluation. Marked differences in the pattern of genomic alterations existed between and within histological subtypes, thus challenging the original histomorphological diagnosis. Immunohistochemical studies confirmed many of these reassigned subtypes. The reassignment eliminated almost all cases of large cell carcinomas, some of which had therapeutically relevant alterations. Prospective testing of our genomics-based diagnostic algorithm in 5145 lung cancer patients enabled a genome-based diagnosis in 3863 (75%) patients, confirmed the feasibility of rational reassignments of large cell lung cancer, and led to improvement in overall survival in patients with EGFR-mutant or ALK-rearranged cancers. Thus, our findings provide support for broad implementation of genome-based diagnosis of lung cancer.

449 citations


Authors

Showing all 22435 results

NameH-indexPapersCitations
Cornelia M. van Duijn1831030146009
Veikko Salomaa162843135046
Andreas Pfeiffer1491756131080
Bernhard O. Palsson14783185051
Robert Huber13967173557
Joachim Heinrich136130976887
Michael Schmitt1342007114667
Paul D.P. Pharoah13079471338
David Robertson127110667914
Yuri S. Kivshar126184579415
Ulrich S. Schubert122222985604
Andreas Hochhaus11792368685
Werner Seeger114111357464
Th. Henning110103644699
Sascha Husa10736269907
Network Information
Related Institutions (5)
Ludwig Maximilian University of Munich
161.5K papers, 5.7M citations

95% related

Heidelberg University
119.1K papers, 4.6M citations

93% related

Technische Universität München
123.4K papers, 4M citations

93% related

University of Bern
79.4K papers, 3.1M citations

92% related

Max Planck Society
406.2K papers, 19.5M citations

92% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
2023129
2022452
20212,257
20202,198
20192,062
20181,803